Insulin Resistance as a Therapeutic Target for Improved Endothelial Function:Metformin

Publisher： Bentham Science Publishers

E-ISSN： 1875-5895|4|1|53-63

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.4, Iss.1, 2004-03, pp. : 53-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Mechanisms of Impaired Endothelial Function Associated with Insulin Resistance

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: Insulin Resistance and Impaired Coronary Endothelial Function (Guest Editor: Teruo Inoue)]

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 1, 2004-01 ,pp. : i-i

Bentham Science Publishers

Access to resources Recommend Favorite

-Cell Expansion for Therapeutic Compensation of Insulin Resistance in Type 2 Diabetes

By Efrat S.  

International Journal of Experimental Diabetes Research, Vol. 4, Iss. 1, 2003-01 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

The Fatty Liver and Insulin Resistance

By  

Current Molecular Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 287-295

Bentham Science Publishers

Access to resources Recommend Favorite

Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia

By  

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 653-661

Bentham Science Publishers

Access to resources Recommend Favorite